Registration opens for 2023 International Space Station Research and Development Conference in Seattle

Science educator Dr. Ainissa Ramirez to give keynote address

2023-04-25

(Press-News.org) Registration is now open for the 12th annual International Space Station Research and Development Conference (ISSRDC), July 31-August 3, 2023, at the Hyatt Regency Hotel in Seattle, Washington.

ISSRDC brings together leaders from the commercial sector, U.S. government agencies, and academic communities to foster innovation and discovery onboard the International Space Station (ISS). ISSRDC 2023 will showcase how the space station continues to provide a valuable
platform for research and technology development that benefits humanity and enables a robust and sustainable market in low Earth orbit.

Science educator and award-winning author Ainissa Ramirez, Ph.D., will join the conference as a keynote speaker. Dr. Ramirez is a science, technology, engineering, and mathematics (STEM) education advocate who speaks internationally on the importance of making science fun and understandable to audiences of all ages, and has delivered a TED talk on the importance of science education. She has been awarded prizes from the U.S. National Science Foundation, the Alfred P. Sloan Foundation, the Massachusetts Institute of Technology, and the American Institute of Physics.

Dr. Ramirez received her bachelor’s degree from Brown University and her doctorate from Stanford, both in materials science and engineering. She began her career as a scientist at Bell Laboratories in Murray Hill, New Jersey, where she created award-winning inventions and received six patents. Dr. Ramirez then joined the faculty at Yale, where she rose to the rank of associate professor of mechanical engineering. She is also the author of the award-winning book “The Alchemy of Us: How Humans and Matter Transformed One Another” (The MIT Press, 2020), which examines how technology shaped humanity.

A series of announcements in the coming weeks will highlight other dynamic keynote speakers and panel sessions for ISSRDC 2023. In addition, this year’s conference will feature plenary presentations, technical sessions, workshops, and an investor session. A marketplace expo will allow companies to showcase how they are advancing opportunities in low Earth orbit and will provide a venue to meet with researchers and stakeholders.

The conference is hosted by the Center for the Advancement of Science in Space, Inc. (CASIS), manager of the ISS National Laboratory; NASA; and the American Astronautical Society (AAS). While this is an in-person event, those not able to travel to Seattle will have the opportunity to view keynotes and plenary sessions via livestream.

To learn more about the conference, including how to register, exhibit, and become a sponsor for ISSRDC, please visit www.issconference.org.

END

ELSE PRESS RELEASES FROM THIS DATE:

New iPad app lets doctors assess components of cognition in five minutes or less

2023-04-25

More than 50 tests span cognition, motor, sensation and emotion to assess a wide range of diseases ‘The problem in clinical care today is nobody has time for long tests for everything’ Earlier version of app now used by 3,000 researchers globally (e.g. COVID ‘brain fog’) CHICAGO --- An iPad app developed at Northwestern Medicine that helps measure specific aspects of cognitive, motor, sensory and emotional function in five minutes or less is now available for doctors to screen people ages 3 to 85+ for a wide range of neurological diseases and syndromes. Using the NIH Toolbox® V3 iPad App, ...

Presenting information about mental health in a second language could help counter cultural norms against treatment

2023-04-25

Public health outreach efforts often strive to overcome communication barriers by using interpretation and translation to present information to communities in their native language. However, bilingual people from cultural backgrounds in which mental health is a particularly taboo topic may be more likely to support treatment when they hear information in their second language, said Leigh H. Grant (University of Chicago) about her findings in Clinical Psychological Science. Chinese speakers with English as second language “were consistently ...

Researchers capture first atomic-scale images depicting early stages of particle accelerator film formation

2023-04-25

Researchers from Prof. Steve Sibener's group have captured the first atomic-scale images of tin on niobium during the growth process of the next generation of particle accelerators, Nb3Sn. The study, published in the Journal of Physical Chemistry C, reveals the potential for greater control over the growth of superconducting Nb3Sn films, which could significantly reduce the cost and size of cryogenic infrastructure required for superconducting technology. Superconducting accelerator facilities, such as those used for X-ray free-electron laser radiation, rely on niobium superconducting ...

Thich Nhat Hanh Center for Mindfulness in Public Health launched at Harvard T.H. Chan School of Public Health

2023-04-25

Boston, MA – The Thich Nhat Hanh Center for Mindfulness in Public Health will launch April 26 at the Harvard T.H. Chan School of Public Health. The Center was created with a $25 million gift from an anonymous donor, one of the largest single donations to the School. The Center’s mission is to empower people around the globe to live with purpose, equanimity, and joy through the practice of mindfulness; pursue evidence-based approaches to improve health and well-being through mindfulness; and educate and train the public in mindfulness. Two primary areas of emphasis will be nutrition and the environment. “We are thrilled to host this groundbreaking ...

What is the best lymphoma treatment after CAR T therapy fails?

2023-04-25

For 30% to 40% of lymphoma patients who receive CAR T therapy, the treatment is a godsend. Typically given to lymphoma patients for whom other treatments have proven ineffective, CAR T therapy involves removing immune cells from the body via a blood draw, reengineering them to become better cancer fighters, then reintroducing them to the bloodstream, where they seek out and destroy cancer cells. For 60% to 70% of lymphoma patients who receive CAR T therapy, however, the treatment doesn’t work, and the cancer comes back — typically within ...

ASTRO and ESTRO issue clinical guideline on local therapy for oligometastatic lung cancer

2023-04-25

ARLINGTON, Va., April 25, 2023 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) and European Society for Radiotherapy & Oncology (ESTRO) provides guidance on the use of definitive local therapy—including radiation and surgery—to treat patients with oligometastatic non-small cell lung cancer (NSCLC). The guideline is published in Practical Radiation Oncology. The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease, a description for cancer that reaches a state in which the patient has a small number of metastases in addition to a primary tumor. ...

Woodpecker guides post-fire forest management

2023-04-25

Ithaca, NY—What's good for the Black-backed Woodpecker is good for restoration of burned California forests. The birds' unique relationship with fire underpins the latest research into improved post-fire management. A study published in Ecological Applications describes a new tool that factors how fires burn into forest management decisions and turns science into action for wildlife conservation. "Wildfire is like a 10,000-piece puzzle, and climate change is rearranging the pieces," said lead author Andrew Stillman with the Cornell Atkinson Center for Sustainability and the Cornell Lab of Ornithology. "Gigantic, severe fires ...

Emerging treatment for children with long COVID and recurrent fever

2023-04-25

Researchers at National Jewish Health found that a subset of children suffering recurring fevers as a result of long COVID-19, benefited from a daily medication treatment commonly used for gout and periodic fever syndrome. Using the drug Colchicine, researchers saw rapid improvement not only in their fevers but also with other long COVID symptoms such as brain fog, fatigue, and achiness. The case study was just published in Journal of Allergy and Clinical Immunology, (JACI: In Practice). Long COVID is defined as persistent symptoms lasting ...

nTIDE April 2023 Deeper Dive: Hispanics with disabilities making historic rebound in job market post-COVID-19 shutdown

2023-04-25

East Hanover, NJ – April 25, 2023 – New data shows that Hispanics with disabilities in the United States rebounded to historic levels in the labor force following the first 12-month period of the COVID-19 pandemic. While the disparity between their non-Hispanic white counterparts remains, their recovery has narrowed this gap and surpassed that of their black/African American counterparts, according to experts speaking during last Friday’s nTIDE Deeper Dive Lunch & Learn Webinar. To further improve employment opportunities ...

Laser speckle imaging can identify hearts suitable for transplantation

2023-04-25

In the majority of cases, graft failure after heart transplantation is attributable to abnormalities like severe coronary artery disease. As donors with extended criteria like advanced age and pre-existing heart conditions become eligible for heart transplantation, careful screening for congenital abnormalities has become crucial. Invasive coronary angiography is an essential screening tool that can detect coronary artery disease (CAD), a condition characterized by cholesterol deposits in the heart's arteries. However, logistical challenges limit utility so it’s used for fewer than a third of donors who are at risk of developing CAD. To overcome this limitation, a new heart ...

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Registration opens for 2023 International Space Station Research and Development Conference in Seattle

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: